Sandip Sabale

Role: Research Scientist, Api Process Development at Alivus Life Sciences
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Sandip Sabale

Doctor of Philosophy (Ph.D.) focused in Organic Chemistry from Institute Of Chemical Technology. Currently working with Alivus Lifesciences, Mumbai.Highly experienced in Iron complex API synthesis, Aluminium complex API synthesis, Synthesis of polymer calcium complex API.Having thorough knowledge and experience in Physicochemical characterisation and Sameness studies of Complex APIs. Thorough understanding of regulatory requirements and regulatory deficiencies for Complex injectables from Drug substance to Drug products. Proven skills in technology transfer of complex products with control on quality in commercial production. Highly experienced in Synthesis of Oncology APIs and their technology transfer.

Experience

Research Scientist, Api Process Development
Alivus Life Sciences
Mar 2025 — Present · Mumbai, IN

Education

Institute Of Chemical Technology
Doctor of Philosophy (Ph.D.), Organic Chemistry
2011 — 2017
Savitribai Phule Pune University
M.Sc, Chemistry
2005 — 2007

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@alivus.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Alivus Life Sciences

Pharmaceutical Manufacturing · 619 employees · Founded 2019 · E Mumbai, Maharashtra, India

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited), is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. The company is increasingly providing CDMO services to a range of multinational and specialty pharmaceutical companies. It has a diversified portfolio of 161 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan, and the Rest of the World (RoW). The company’s four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed capacity of 1424 KL, which are regularly inspected by global regulators such as USFDA, PMDA (Japan) and EDQM (Europe). Alivus Life Sciences is listed on BSE and NSE. The company’s journey as an independent entity began in 2019, branching off from Glenmark Pharmaceuticals to focus solely on building an API business. Since then, the API business has charted a strong course and flourished independently to pave the way for a distinctive growth trajectory. FY24 marked a significant milestone for the company, due to a change of ownership from Glenmark Pharmaceuticals to Nirma. The key differentiator for Alivus is its people. The knowledgeable, responsible and inspired team, of almost employees from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. Powered by its world-class manufacturing and research capabilities, Alivus supplies high-quality APIs to more than 700 pharma companies in over 70 countries. As part of its evolving vision, the company is further strengthening its global presence and committing to provide innovative solutions in the API and CDMO space.

alivus.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Sandip Sabale

Experience

Research Scientist, Api Process Development

Education

Institute Of Chemical Technology

Savitribai Phule Pune University

Find verified contacts for anyone on LinkedIn